After Rough First Day, Revamped Billiken Finds a Little CheerThe school seems to be taking the complaints in stride.
SLU's New Billiken Mascot: Updated or Unsettling?Saint Louis University revealed its new Billiken mascot Tuesday, and video and photos of the modernized Billiken quickly sparked social media backlash.
Weight-Loss Methods Yield Similar Results Says SLU StudyWhich works better to improve the cardiovascular health of overweight people: dieting, exercise or a combination of both?
Festival of Nations to Celebrate Diversity at Tower Grove ParkThe Festival of Nations is "a giant world party" featuring food, music and entertainment from more than 40 nations and ethnicities.
Local Marijuana Dispensary Owner Praises DEA for Research AllowanceMarijuana is still on the official list of dangerous drugs, but the Drug Enforcement Agency now says it will allow more research into its medicinal use.
SLU Opens First New Dorm in 2 DecadesSpring Hall includes outside fire pits and classroom.
There Are Real Benefits to Taking a Break From WorkEmployers who fully support "time off" have noticed an increase in employee well-being and group productivity.
When it Comes to Women Leading Nations, U.S. is Behind. Why?When it comes to women leading nations, the United States is late to the party. But why?
SLU Doctors Test More Universal Yellow Fever VaccineThe current vaccine is made from a weakened strain of the live virus, so it's not recommended for those who have challenged immune systems.
SLU Vaccine Center to Test Zika Vaccine on HumansOnce SLU researchers have initial safety data from the St. Louis trial, they will start up a second parallel study in Puerto Rico.
SLU's New Half-Billion Dollar Hospital Going Next to Old OneIt will be a 316 bed, 802,000 square foot facility, according to master plans unveiled Monday by SLU and partner SSM Health.
Local Researcher Pushes For Diverse Lab Mice in Cancer StudiesSaint Louis University microbiologist and immunologist Dr. Ryan Teague says researchers should include laboratory mice who are old and obese in their studies of immunotherapy treatments for cancer.